IWC
JANX icon

Integrated Wealth Concepts’s Janux Therapeutics JANX Stock Holding History

Integrated Wealth Concepts’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.96K Buy
+453
New +$6.56K ﹤0.01% 4787

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Integrated Wealth Concepts's JANX Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in Janux Therapeutics (JANX) in Q2 2026: 453 shares worth $6.96K. The stake represents ﹤0.01% of the portfolio and ranks #4787 among its holdings.

197 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • Integrated Wealth Concepts held 453 shares of Janux Therapeutics worth $6.96K as of Q2 2026.
  • Janux Therapeutics was a new Integrated Wealth Concepts position in Q2 2026.
  • Janux Therapeutics made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #4787 holding.
  • 197 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.